We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form
of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses
and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain TM, or C&C, hydrogel technology, comprised
of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask”
with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such
as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. We refer to our additional
technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or
APIs, as Trap and Target ™, or T&T.
Company Details
- Employees
- 8
- Founded
- 2005
- Address
- Raanana, Meẖoz Hamerkaz 4343306, Il
- su****@****zon.com
- Industry
- Biotechnology
- Website
- polyrizon.com
- HQ
- Raanana, Meẖoz HaMerkaz
Polyrizon Ltd. Questions
Polyrizon Ltd.'s website is polyrizon.com
Polyrizon Ltd.'s LinkedIn profile is https://il.linkedin.com/company/polyrizon-ltd-
Polyrizon Ltd. has
8 employees.
View email and phone details for 8
employees at Polyrizon Ltd..
Polyrizon Ltd.'s industry is
Biotechnology
Polyrizon Ltd.'s top competitors are
Inmed Pharmaceuticals,
Rail Vision Ltd,
Shimony Financial Services,
Greenlane Holdings, Inc. (Nasdaq: Gnln),
Epicrispr Biotechnologies,
Calidi Biotherapeutics,
Prophet,
Aegis Capital Corp.,
Hillstar Bio,
Lmf Medical.
Polyrizon Ltd.'s support email address is support@polyrizon.com
Polyrizon Ltd.'s categories are Biotechnology
Polyrizon Ltd.'s founding year is 2005
